Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Review uri icon

Overview

abstract

  • The use of antibiotics in acute exacerbations of chronic bronchitis (AECBs) remains the subject of controversy despite considerable medical and socioeconomic implications. First, the contribution of bacterial infection to AECBs is difficult to assess in patients with chronic obstructive pulmonary disease (COPD) who are chronically colonized with respiratory pathogens. In addition, several studies suggest a major role of viral infections in AECBs. Secondly, it is unlikely that all COPD patients will benefit from antibiotics during AECBs. In particular, the benefit in mild COPD remains uncertain. Unfortunately, the number of studies complying with evidence-based medicine requirements is too small for definite recommendations in AECBs to be drawn up. Considering the impact of acute exacerbations of chronic bronchitis on chronic obstructive pulmonary disease patients, as well as the community, and the impact of antibiotic therapy on the development of bacterial resistance, there is an urgent need for the design of appropriate multicentric studies to define the usefulness of this type of treatment in acute exacerbations of chronic bronchitis.

publication date

  • May 1, 2002

Research

keywords

  • Anti-Bacterial Agents
  • Bronchitis, Chronic
  • Pulmonary Disease, Chronic Obstructive
  • Respiratory Tract Infections

Identity

Scopus Document Identifier

  • 0036014560

PubMed ID

  • 12030740

Additional Document Info

volume

  • 19

issue

  • 5